Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.3K

Psychosocial issues in patients with chronic hepatitis B and C

Aurelia Enescu1, P Mitrut2, Maria Balasoiu3

  • 1Emergency Medicine Discipline, University of Medicine and Pharmacy of Craiova, Romania.

Current Health Sciences Journal
|March 3, 2015
PubMed

Insights

Psychosocial factors significantly impact the quality of life for patients with chronic hepatitis B and C. Improved psychosocial education and support are crucial for managing mental health and reducing stigmatization in these individuals.

Area of Science:

  • Hepatology
  • Psychiatry
  • Public Health

Background:

  • Psychosocial issues and quality of life are critical for patients with chronic hepatitis B and C.
  • Chronic hepatitis B patients show increased psychosocial disorders, influenced by alcohol abuse and low social support.
  • Chronic hepatitis C prevalence is significantly higher in individuals with severe mental illness.

Purpose of the Study:

  • To explore the interplay between psychosocial factors, quality of life, and mental health in chronic hepatitis B and C patients.
  • To highlight the need for enhanced psychosocial education and treatment strategies.
  • To investigate the higher risk of hepatitis B infection among psychiatric patients.

Main Methods:

  • Comparative analysis of quality of life and mental health in chronic hepatitis B versus C patients.
  • Review of factors impacting mental health, including alcohol abuse and social support.
  • Examination of hepatitis C prevalence in mentally ill populations and hepatitis B risk in psychiatric patients.
  • Assessment of societal stigmatization associated with viral hepatitis.

Main Results:

  • Patients with chronic hepatitis B generally report better quality of life and mental health than those with chronic hepatitis C.
  • Alcohol abuse and limited social support negatively affect the mental well-being of hepatitis B patients.
  • Psychiatric patients, particularly institutionalized individuals, face a heightened risk of hepatitis B infection.
  • Both hepatitis B and C patients experience significant social stigmatization.

Conclusions:

  • Chronic viral hepatitis significantly impacts patients' psychosocial well-being and quality of life.
  • Tailored psychosocial interventions and education are essential for managing these conditions effectively.
  • Despite challenges, interferon treatment is feasible and safe for patients with viral hepatitis and psychiatric comorbidities.

Keywords:
: chronic hepatitis B and Cdepressionquality of lifestigma

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

12.3K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.4K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
63
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
358
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
946
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
825
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
359